H.C. Wainwright Sticks to Its Buy Rating for Perpetua Resources (PPTA)
In a report released today, Heiko Ihle from H.C. Wainwright reiterated a Buy rating on Perpetua Resources (PPTA – Research Report), with a ...
Perpetua Resources price target raised to $28 from $25 at H.C. Wainwright
H.C. Wainwright analyst Heiko Ihle raised the firm’s price target on Perpetua Resources (PPTA) to $28 from $25 and keeps a Buy rating on the ...
Alpha Cognition Is 'Under-Followed' As Alzheimer Drug Targets $2 Billion Long Term Care Market: Analyst
HC Wainwright initiated coverage on Alpha Cognition, noting a new twist on a tried-and-tested treatment paradigm.
Fintel on MSN4d
HC Wainwright & Co. Initiates Coverage of Actuate Therapeutics (ACTU) with Buy Recommendation
Fintel reports that on March 17, 2025, HC Wainwright & Co. initiated coverage of Actuate Therapeutics (NasdaqGM:ACTU) with a ...
HC Wainwright Reaffirms Buy Rating for Werewolf Therapeutics (NASDAQ:HOWL)
HC Wainwright reiterated their buy rating on shares of Werewolf Therapeutics (NASDAQ:HOWL – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $15 ...
What is HC Wainwright’s Estimate for WWR FY2024 Earnings?
HC Wainwright issued their FY2024 earnings per share (EPS) estimates for Westwater Resources in a research report issued to ...
Stocktwits on MSN9d
Core Scientific Stock Gains As HC Wainwright Reiterates Rating On CoreWeave's $12B OpenAI Deal: Retail Stays Extremely Bullish
Shares of Core Scientific Inc. (CORZ) gained almost 8% in Tuesday’s regular session and extended gains during after-hours ...
Finanznachrichten15d
Cantargia to Participate at H.C. Wainwright's Annual Autoimmune & Inflammatory Virtual Conference
Fireside chat Damian Marron, interim CEO, will participate in a fireside chat moderated by Joe Pantginis, Managing Director, Equity Research at H.C. Wainwright & Co., LLC. March 27 at 08.00am EST ...
Investing16d
H.C. Wainwright maintains Neutral on Cassava Sciences stock
On Wednesday, H.C. Wainwright reiterated a Neutral rating on Cassava Sciences (NASDAQ:SAVA), following the company’s announcement of its financial and operational results for the fiscal year that ...
Yahoo Finance16d
H.C. Wainwright focused on what results from Cassava’s ReFocus-ALZ might reveal
https://www.tipranks.com/news/the-fly/h-c-wainwright-says-novo-results-support-viking-obesity-potential H.C. Wainwright notes that Neutral-rated Cassava Sciences ...